Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers.

ABSTRACT: Bladder cancer and renal cell carcinoma (RCC) are the second and third most commonly diagnosed cancers in the field of uro-oncology [...].

SUBMITTER: Pichler R 

PROVIDER: S-EPMC7601394 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature